QA: Shuttle Pharmaceuticals Holdings Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001757499_2024_Shuttle_Pharmaceuticals_Holdings_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001757499, Shuttle Pharmaceuticals Holdings Inc

  xvar xval
0 AssetsCurrent 5,593,005
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 24,827
3 remainder_Assets 333,904
4 LiabilitiesCurrent 1,042,237
5 LiabilitiesNoncurrent 304,127
6 remainder_Liabilities 549,601
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,046,854
9 ResearchAndDevelopmentExpense 3,517,093
10 remainder_Expenses 1,328,435
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,951,736
1 Liabilities 1,895,965
2 Expenses 5,892,382
3 Revenues 0
4 StockholdersEquity 4,055,771
5 NetIncome -5,892,382
6 ComprehensiveNetIncome -5,892,382
7 BaseVar 6,870,042
8 EconomicCapitalRatiobeforeLimitedLiability 0.752
9 EconomicCapitalRatio 2.10

Edgar->Model Mapping

Feature Distribution

Change over Time